L-5-Hydroxytryptophan in Depression: the First Substitution Therapy in Psychiatry?

doi:https://doi.org/10.1159/000117757

L-5-Hydroxytryptophan in Depression: the First Substitution Therapy in Psychiatry?

L.J. van Hiele-1980-01-01-Neuropsychobiology

88

TL;DRAbstract

99 ‘therapy-resistant’ depressive out-patients were treated with l-5-hydroxytrypto-phan combined with the peripheral decarboxylase inhibitor, carbidopa. This treatment produced an astonishing recovery without side effects in some 50% of the patients.

Chat with Paper

AI Agents for this Paper

99 ‘therapy-resistant’ depressive out-patients were treated with l-5-hydroxytrypto-phan combined with the peripheral decarboxylase inhibitor, carbidopa. This treatment produced an astonishing recovery without side effects in some 50% of the patients.

Keywords

Carbidopa5-HydroxytryptophanDepression (economics)PsychiatryMedicinePsychologyInternal medicineSerotonin

Chat

Click to start Chat